IN8BIO INC (INAB) Stock Earnings & Estimates
USA - NASDAQ:INAB - US45674E1091 - Common Stock
2.1 USD
+0.01 (+0.48%)
2.16 USD
+0.06 (+2.86%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 883.51% | N/A 230.14% | N/A 57.76% | N/A -17.22% | N/A 33.93% | ||||||||
| EBITDA YoY % growth | -1.9M | -4.96M -161.05% | -8.47M -70.77% | -14.02M -65.53% | -27.91M -99.07% | -27.836M 0.27% | -26.944M 3.20% | N/A 43.22% | N/A -73.33% | N/A -80.77% | N/A 29.79% | N/A -15.15% | N/A 76.32% | N/A 288.89% | N/A 141.18% | |
| EBIT YoY % growth | -2M | -5.06M -153.00% | -8.56M -69.17% | -14.65M -71.14% | -28.52M -94.68% | -30.337M -6.37% | -29.599M 2.43% | N/A 32.98% | N/A -15.71% | N/A -3.89% | N/A 77.90% | N/A 726.39% | N/A 117.93% | N/A -82.42% | N/A 191.13% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -42.60 10.76% | -30.30 28.87% | -17.40 42.57% | N/A 60.72% | N/A 24.58% | N/A 11.02% | N/A 108.30% | N/A 1,708.20% | N/A 84.44% | N/A -78.31% | N/A 200.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -1.25 72.12% | -0.94 21.80% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -4.625M 32.09% | -4.575M 26.49% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.24 78.25% | -1.84 | 0.60 | 32.46% |
| Q1 2025 Q2Q % growth | -2.10 65.00% | -2.04 | -0.06 | -2.94% |
| Q4 2024 Q2Q % growth | -1.20 80.95% | -2.30 | 1.10 | 47.71% |
| Q3 2024 Q2Q % growth | -4.50 34.78% | -4.90 | 0.40 | 8.09% |
| Q2 2024 Q2Q % growth | -5.70 29.63% | -5.14 | -0.56 | -10.88% |
| Q1 2024 Q2Q % growth | -6.00 33.33% | -5.43 | -0.57 | -10.47% |
| Q4 2023 Q2Q % growth | -6.30 43.24% | -4.69 | -1.61 | -34.27% |
| Q3 2023 Q2Q % growth | -6.90 32.35% | -7.50 | 0.60 | 7.96% |
| Q2 2023 Q2Q % growth | -8.10 28.95% | -8.26 | 0.16 | 1.96% |
| Q1 2023 Q2Q % growth | -9.00 9.09% | -9.79 | 0.79 | 8.09% |
| Q4 2022 Q2Q % growth | -11.10 -76.19% | -9.69 | -1.41 | -14.55% |
| Q3 2022 Q2Q % growth | -10.20 -36.00% | -8.98 | -1.22 | -13.64% |
| Q2 2022 Q2Q % growth | -11.40 -1,040.00% | -8.87 | -2.53 | -28.47% |
| Q1 2022 Q2Q % growth | -9.90 | -10.10 | 0.20 | 1.96% |
| Q4 2021 Q2Q % growth | -6.30 | -8.11 | 1.81 | 22.31% |
| Q3 2021 Q2Q % growth | -7.50 | -8.42 | 0.92 | 10.87% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 23.12% | 23.12% | 0% | -3090.48% |
| Revenue | N/A | N/A | N/A | N/A |